mn(iii) 5,10,15,20-tetrakis(n-methylpyridinium-2-yl)porphyrin has been researched along with Acute Ischemic Stroke in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Moreton, N; O'Connor, JJ; Puzio, M | 1 |
1 other study(ies) available for mn(iii) 5,10,15,20-tetrakis(n-methylpyridinium-2-yl)porphyrin and Acute Ischemic Stroke
| Article | Year |
|---|---|
The effects of the superoxide dismutase mimetic, MnTMPyP, post hypoxia and oxygen glucose deprivation in isolated rat hippocampal slices.
Topics: Animals; Glucose; Hippocampus; Hypoxia; Ischemic Stroke; Neuroprotective Agents; Oxygen; Purinergic P1 Receptor Antagonists; Rats; Superoxide Dismutase | 2022 |